The effects of subcutaneous allergen immunotherapy by Alutard SQ allergy vaccination in management of perennial allergic rhinitis.
- Author:
Zheng FU
1
;
Xia LIN
;
Fei CAI
;
Gang WANG
;
Huilin DENG
;
Qing LI
;
Xiaojuan WANG
Author Information
1. Department of Otorhinolaryngology Head and Neck Surgery, Hainan Province People's Hospital, Haikou. Fuzheng62310@163.com
- Publication Type:Journal Article
- MeSH:
Adolescent;
Adult;
Animals;
Child;
Child, Preschool;
Desensitization, Immunologic;
Female;
Humans;
Male;
Pyroglyphidae;
immunology;
Rhinitis, Allergic;
Rhinitis, Allergic, Perennial;
therapy;
Treatment Outcome;
Vaccination;
Young Adult
- From:
Journal of Clinical Otorhinolaryngology Head and Neck Surgery
2012;26(16):744-746
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVE:To study the effects of subcutaneous allergen immunotherapy by Alutard SQ allergy vaccination in management of perennial allergic rhinitis.
METHOD:Thirty-eight cases of the perennial allergic rhinitis received the subcutaneous allergen immunotherapy by Alutard SQ allergy vaccination for 3 years or more than 3 years. The clinical symptoms and signs were compared before and after treatment.
RESULT:Good result were obtained in 21 of 38 cases, 7 cases effective, and 10 cases ineffective. Total effective rate was 73.68%.
CONCLUSION:The subcutaneous allergen immunotherapy by Alutard SQ allergy vaccination was very effective for the perennial allergen rhinitis.
